SEARCH RESULTS for GLAXOSMITHKLINE BIOLOGICALS SA

Recent Patent Assignments Patent Assignments - (Total found: 187)

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame

(X0) 14375222: PROMOTERS FOR INCREASED PROTEIN EXPRESSION IN MENINGOCOCCUS

(A1) 20150218566: PROMOTERS FOR INCREASED PROTEIN EXPRESSION IN MENINGOCOCCUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/126

(X0) 14410728: IMMUNOGENIC COMPOSITIONS AND USES THEREOF

(A1) 20150140068: IMMUNOGENIC COMPOSITIONS AND USES THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/237

(X0) 14410461: COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

(A1) 20160159864: COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/292

(X0) 14396881: ANTIGENS AND ANTIGEN COMBINATIONS

(A1) 20150202279: ANTIGENS AND ANTIGEN COMBINATIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/303

(X0) 14363383: METHOD OF DETECTING THE PRESENCE OF AN ANTIBODY IN A SAMPLE

(A1) 20140335544: METHOD OF DETECTING THE PRESENCE OF AN ANTIBODY IN A SAMPLE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/308

(X0) 14408466: STABILIZED GP120

(A1) 20150183835: STABILIZED GP120

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/336

7666436: PERTUSSIS TOXIN MUTANTS, BORDETELLA STRAINS CAPABLE OF PRODUCING SUCH MUTANTS AND THEIR USE IN THE DEVELOPMENT OF ANTIPERTUSSIS VACCINES

7427404: PERTUSSIS TOXIN MUTANTS, BORDETELLA STRAINS CAPABLE OF PRODUCING SUCH MUTANTS AND THEIR USE IN THE DEVELOPMENT OF ANTIPERTUSSIS VACCINES

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38986/402

(X0) 14240020: PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

(A1) 20140255472: PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39078/876

(X0) 14130748: LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

(A1) 20140141070: LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39079/945

(X0) 14130880: OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

(A1) 20140212498: OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39080/188

(X0) 14130886: CATIONIC OIL-IN-WATER EMULSIONS

(A1) 20140220083: CATIONIC OIL-IN-WATER EMULSIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39080/409

(X0) 14368957: ADJUVANTED COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEINS

(A1) 20150209419: ADJUVANTED COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEINS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39082/108

(X0) 14234648: COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

(A1) 20140170187: COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39082/322

(X0) 13878835: ANTIGEN DELIVERY PLATFORMS

(A1) 20140030292: ANTIGEN DELIVERY PLATFORMS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39082/689

(X0) 13574958: IRRADIATED BIODEGRADABLE POLYMER MICROPARTICLES

(A1) 20130101609: IRRADIATED BIODEGRADABLE POLYMER MICROPARTICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39083/10

9296796: STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39531/658

(X0) 14918417: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

(A1) 20160039887: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39292/434

8637044: Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8168194: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) TAT SCAFFOLD POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZATION EPITOPES.

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39315/838

(X0) 14714097: PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES

(A1) 20150315225: PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39323/443

(X0) 14989737: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

(A1) 20160199476: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39336/946

9156894: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8398999: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8226960: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

NOVARTIS AG

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39348/942

(X0) 14571807: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(A1) 20150175670: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(B2) 9409957: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

BLAIS, NORMAND

LABBE, STEVE

POOLMAN, JAN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

34546/777

(X0) 14927052: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

(A1) 20160108094: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

40063/166

(X0) 10148533: Compositions Comprising Neisseria Meningitidis Antigens From Serogroups B and C

(A1) 20050074450: Compositions Comprising Neisseria Meningitidis Antigens From Serogroups B and C

NOVARTIS VACCINES AND DIAGNOSTICS SRL

GLAXOSMITHKLINE BIOLOGICALS SA

40077/483

7604810: CONSERVED NEISSERIAL ANTIGENS

9169301: Conserved neisserial antigens

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/493

9364528: COMBINATION NEISSERIAL COMPOSITIONS

7862827: COMBINATION NEISSERIAL COMPOSITIONS

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/536

8025890: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B

8431139: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B

7955604: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B

7939087: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B

8137673: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/574

7504111: GONOCOCCAL PROTEINS AND NUCLEIC ACIDS

8642050: GONOCOCCAL PROTEINS AND NUCLEIC ACIDS

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/595

(X0) 14224031: MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40

(A1) 20140294884: MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40

(B2) 9249197: MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/642

RE45587: VACCINES COMPRISING ALUMINUM ADJUVANTS AND HISTIDINE

7348006: VACCINES COMPRISING ALUMINIUM ADJUVANTS AND HISTIDINE

7754218: VACCINES COMPRISING ALUMINUM ADJUVANTS AND HISTIDINE

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/682

9011869: HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS

8840907: AN ISOLATED PROTEIN AND COMPOSITIONS COMPRISING THE PROTEIN

9056075: METHODS OF INDUCING AN IMMUNE RESPONSE WITH COMPOSITIONS COMPRISING A NEISSERIA MENINGITIDIS 741 PROTEIN

8980277: HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/722

8226960: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8398999: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

9156894: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/814

(X0) 10530753: POLYPEPTIDE-VACCINES FOR BROAD PROTECTION AGAINST HYPERVIRULENT MENINGOCOCCAL LINEAGES

(A1) 20060171957: POLYPEPTIDE-VACCINES FOR BROAD PROTECTION AGAINST HYPERVIRULENT MENINGOCOCCAL LINEAGES

(B2) 8663656: POLYPEPTIDE-VACCINES FOR BROAD PROTECTION AGAINST HYPERVIRULENT MENINGOCOCCAL LINEAGES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/860

7608276: STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS

8465750: STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/901

(X0) 10552192: ADP-RIBOSYLATING TOXIN FROM LISTERIA MONOCYTOGENES

(A1) 20090297542: ADP-RIBOSYLATING TOXIN FROM LISTERIA MONOCYTOGENES

(B2) 8398986: ADP-RIBOSYLATING TOXIN FROM LISTERIA MONOCYTOGENES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40077/928

8513392: Conjugation of streptococcal capsular saccharides

9040055: CONJUGATION OF STREPTOCOCCAL CAPSULAR SACCHARIDES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40078/21

7749518: POLYPEPTIDES FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE

8124098: POLYPEPTIDES FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE

9102729: POLYPEPTIDES FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40078/90